Biography

Baroness Greenfield has engaged on health and social care through four debate speeches, with a particular focus on dementia and Alzheimer's disease as an urgent policy priority, citing projections of rising costs and prevalence. She has consistently declared her interest as CEO of a biotech company developing Alzheimer's treatments, and has raised concerns about government support for small biotech firms and R&D tax credits. Her contributions have also touched on mental health, women in science, and the economic value of medical innovation to the UK.

Generated from their own Hansard record, below

…In the UK, current costs for dementia will be £42 billion this year, rising to £90 billion in 2014. It is clear that finding an effective treatment could have a significant impact on individual well-being, society and our economy. We need an improved national strategy across the areas on which I have briefly touched.

Record by topic

  1. Dementia60th of 2516.0
  2. Cancer503rd of 6222.0
  3. Elderly care & frailty166th of 2362.0
  4. Maternity & neonatal363rd of 4382.0
  5. Mental health750th of 8802.0

What they’ve said

  • …ilar schemes in academia—for example, grants specifically designed to support those re-entering the field after maternity leave. Such initiatives would ensure that women can get back to progressing their research without the undue and unfair hurdles that arise from contributing to the next generation.

    International Women’s Day · 2025-03-06 · Read on Hansard ↗

  • …For example, dementia is costing the UK £42 billion this year, rising to £90 billion in 2040, so the value of developing an effective therapeutic intervention would be enormous, and not only for the huge saving.

    Science and Technology: Economy · 2024-10-31 · Read on Hansard ↗

  • My Lords, as a neuroscientist I welcome consideration of mental health in the gracious Speech. I declare an interest as founder and CEO of a biotech company, Neuro-Bio Ltd, where we are striving towards a novel and effective treatment for Alzheimer’s disease.

    King’s Speech · 2024-07-19 · Read on Hansard ↗

Contributions reproduced under the Open Parliament Licence.